|
DE69626684T2
(de)
*
|
1995-12-08 |
2004-04-29 |
Agouron Pharmaceuticals, Inc., La Jolla |
Metallproteinasehemmer, diesen enthaltende pharmazeutische zusammensetzung und dessen pharmazeutische verwendung und verfahren zu ihrer herstellung
|
|
US6500948B1
(en)
|
1995-12-08 |
2002-12-31 |
Agouron Pharmaceuticals, Inc. |
Metalloproteinase inhibitors-compositions, uses preparation and intermediates thereof
|
|
FR2748026B1
(fr)
*
|
1996-04-26 |
1998-06-05 |
Adir |
Nouveaux inhibiteurs de metalloproteases, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
|
|
KR20000035920A
(ko)
*
|
1996-08-28 |
2000-06-26 |
데이비드 엠 모이어 |
헤테로고리성 메탈로프로테아제 저해제
|
|
US5929097A
(en)
*
|
1996-10-16 |
1999-07-27 |
American Cyanamid Company |
Preparation and use of ortho-sulfonamido aryl hydroxamic acids as matrix metalloproteinase and tace inhibitors
|
|
US6228869B1
(en)
|
1996-10-16 |
2001-05-08 |
American Cyanamid Company |
Ortho-sulfonamido bicyclic hydroxamic acids as matrix metalloproteinase and TACE inhibitors
|
|
US5962481A
(en)
*
|
1996-10-16 |
1999-10-05 |
American Cyanamid Company |
Preparation and use of ortho-sulfonamido heteroaryl hydroxamic acids as matrix metalloproteinase and tace inhibitors
|
|
US6548524B2
(en)
|
1996-10-16 |
2003-04-15 |
American Cyanamid Company |
Preparation and use of ortho-sulfonamido bicyclic heteroaryl hydroxamic acids as matrix metalloproteinase and TACE inhibitors
|
|
US5977408A
(en)
*
|
1996-10-16 |
1999-11-02 |
American Cyanamid Company |
Preparation and use of β-sulfonamido hydroxamic acids as matrix metalloproteinase and TACE inhibitors
|
|
WO1998017645A1
(en)
*
|
1996-10-22 |
1998-04-30 |
Pharmacia & Upjohn Company |
α-AMINO SULFONYL HYDROXAMIC ACIDS AS MATRIX METALLOPROTEINASE INHIBITORS
|
|
US6008243A
(en)
*
|
1996-10-24 |
1999-12-28 |
Agouron Pharmaceuticals, Inc. |
Metalloproteinase inhibitors, pharmaceutical compositions containing them, and their use
|
|
US6174915B1
(en)
|
1997-03-25 |
2001-01-16 |
Agouron Pharmaceuticals, Inc. |
Metalloproteinase inhibitors, pharmaceutical compositions containing them and their pharmaceutical uses
|
|
SG103322A1
(en)
|
1996-10-30 |
2004-04-29 |
Tanabe Seiyaku Co |
S type 2-substituted hydroxy-2-indolidinylbutyric ester compounds and process for preparation thereof
|
|
ZA98376B
(en)
*
|
1997-01-23 |
1998-07-23 |
Hoffmann La Roche |
Sulfamide-metalloprotease inhibitors
|
|
TR199901765T2
(xx)
*
|
1997-01-23 |
1999-10-21 |
F.Hoffmann-La Roche Ag |
S�lfomid-metalloproteaz inhibit�rleri
|
|
US6376506B1
(en)
|
1997-01-23 |
2002-04-23 |
Syntex (U.S.A.) Llc |
Sulfamide-metalloprotease inhibitors
|
|
US5985900A
(en)
*
|
1997-04-01 |
1999-11-16 |
Agouron Pharmaceuticals, Inc. |
Metalloproteinase inhibitors, pharmaceutical compositions containing them and their pharmaceutical uses
|
|
DE19719817A1
(de)
*
|
1997-05-13 |
1998-11-19 |
Hoechst Ag |
Substituierte 6- und 7-Aminotetrahydroisochinolincarbonsäuren
|
|
AU8766498A
(en)
*
|
1997-08-04 |
1999-02-22 |
Amgen, Inc. |
Hydroxamic acid substituted fused heterocyclic metalloproteinase inhibitors
|
|
WO1999018076A1
(en)
*
|
1997-10-06 |
1999-04-15 |
American Cyanamid Company |
The preparation and use of ortho-sulfonamido bicyclic heteroaryl hydroxamic acids as matrix metalloproteinase and tace inhibitors
|
|
US6130220A
(en)
*
|
1997-10-16 |
2000-10-10 |
Syntex (Usa) Inc. |
Sulfamide-metalloprotease inhibitors
|
|
FR2771095B1
(fr)
*
|
1997-11-14 |
1999-12-17 |
Adir |
Nouveaux inhibiteurs de metalloproteases, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
|
|
US6107291A
(en)
*
|
1997-12-19 |
2000-08-22 |
Amgen Inc. |
Azepine or larger medium ring derivatives and methods of use
|
|
US6335329B1
(en)
|
1997-12-19 |
2002-01-01 |
Amgen Inc. |
Carboxylic acid substituted heterocycles, derivatives thereof and methods of use
|
|
KR20010034406A
(ko)
*
|
1998-01-27 |
2001-04-25 |
아메리칸 사이아나미드 컴파니 |
매트릭스 메탈로프로테인아제 억제제로서의2,3,4,5-테트라하이드로-1ｈ-[1,4]-벤조디아제핀-3-하이드록삼산
|
|
US6071903A
(en)
*
|
1998-01-27 |
2000-06-06 |
American Cyanamid Company |
2,3,4,5-tetrahydro-1H-[1,4]-benzodiazepine-3-hydroxyamic acids
|
|
BR9910678A
(pt)
*
|
1998-05-14 |
2001-10-02 |
Du Pont Pharm Co |
Composto, composição farmacêutica, método para traramento ou prevenção de uma doença inflamatória, método para tratamento de uma condição ou uma doença mediada por mmps, tnf, agrecanase, ou um composto dos mesmos, em um mamìfero, método de redução de nìveis de tnf em pacientes, sem a inibição de mmps, método para tratamento de uma condição ou uma doença e uso de um novo composto
|
|
WO2000023443A1
(en)
*
|
1998-10-22 |
2000-04-27 |
Akzo Nobel N.V. |
Tetrahydropyridopyridine derivatives and intermediates for producing the same
|
|
US20040122011A1
(en)
*
|
1998-12-23 |
2004-06-24 |
Pharmacia Corporation |
Method of using a COX-2 inhibitor and a TACE inhibitors as a combination therapy
|
|
US6313123B1
(en)
|
1999-01-27 |
2001-11-06 |
American Cyanamid Company |
Acetylenic sulfonamide thiol tace inhibitors
|
|
US6326516B1
(en)
|
1999-01-27 |
2001-12-04 |
American Cyanamid Company |
Acetylenic β-sulfonamido and phosphinic acid amide hydroxamic acid TACE inhibitors
|
|
AR022423A1
(es)
*
|
1999-01-27 |
2002-09-04 |
American Cyanamid Co |
Compuestos derivados de acidos 2,3,4,5-tetrahidro-1h-[1,4]benzodiazepina-3-hidroxamicos, composicion farmaceutica que los comprenden, y el uso de losmismos para la manufactura de un medicamento
|
|
US6762178B2
(en)
|
1999-01-27 |
2004-07-13 |
Wyeth Holdings Corporation |
Acetylenic aryl sulfonamide and phosphinic acid amide hydroxamic acid TACE inhibitors
|
|
US6277885B1
(en)
|
1999-01-27 |
2001-08-21 |
American Cyanamid Company |
Acetylenic aryl sulfonamide and phosphinic acid amide hydroxamic acid TACE inhibitors
|
|
US6946473B2
(en)
|
1999-01-27 |
2005-09-20 |
Wyeth Holdings Corporation |
Preparation and use of acetylenic ortho-sulfonamido and phosphinic acid amido bicyclic heteroaryl hydroxamic acids as TACE inhibitors
|
|
US6753337B2
(en)
|
1999-01-27 |
2004-06-22 |
Wyeth Holdings Corporation |
Alkynyl containing hydroxamic acid compounds as matrix metalloproteinase/tace inhibitors
|
|
BR0007784A
(pt)
|
1999-01-27 |
2002-02-05 |
American Cyanamid Co |
Composto, método para inibir mudanças patológicas mediadas pela enzima que converte o tnf-alfa (tace) em um mamìfero, composição farmacêutica, e, processo para preparar um composto
|
|
US6340691B1
(en)
|
1999-01-27 |
2002-01-22 |
American Cyanamid Company |
Alkynyl containing hydroxamic acid compounds as matrix metalloproteinase and tace inhibitors
|
|
US6225311B1
(en)
|
1999-01-27 |
2001-05-01 |
American Cyanamid Company |
Acetylenic α-amino acid-based sulfonamide hydroxamic acid tace inhibitors
|
|
US6200996B1
(en)
|
1999-01-27 |
2001-03-13 |
American Cyanamid Company |
Heteroaryl acetylenic sulfonamide and phosphinic acid amide hydroxamic acid tace inhibitors
|
|
US6544984B1
(en)
|
1999-01-27 |
2003-04-08 |
American Cyanamid Company |
2,3,4,5-tetrahydro-1H-(1,4)benzodiazepine-3-hydroxamic acids
|
|
GB9903598D0
(en)
*
|
1999-02-18 |
1999-04-07 |
Univ Manchester |
Connective tissue healing
|
|
CO5261615A1
(es)
|
1999-12-01 |
2003-03-31 |
Agouron Pharma |
Compuestos, composiciones y metodos para estimular el crecimiento y elongacion de neuronas
|
|
GB0011409D0
(en)
*
|
2000-05-11 |
2000-06-28 |
Smithkline Beecham Plc |
Novel compounds
|
|
MXPA01013172A
(es)
|
2001-02-14 |
2002-08-21 |
Warner Lambert Co |
Inhibidores sulfonamida de metaloproteinasa de matriz.
|
|
FR2821842B1
(fr)
*
|
2001-03-07 |
2003-05-09 |
Servier Lab |
Nouveaux derives d'inhibiteurs de mettalloproteases, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
|
|
US6770647B2
(en)
|
2001-08-17 |
2004-08-03 |
Bristol-Myers Squibb Pharma Company |
Bicyclic hydroxamates as inhibitors of matrix metalloproteinases and/or TNF-α converting enzyme (TACE)
|
|
WO2003037852A1
(en)
|
2001-11-01 |
2003-05-08 |
Wyeth Holdings Corporation |
Allenic aryl sulfonamide hydroxamic acids as matrix metalloproteinase and tace inhibitors
|
|
RU2223703C2
(ru)
*
|
2002-02-13 |
2004-02-20 |
Иркутский государственный институт усовершенствования врачей |
Способ лечения передней хронической нестабильности коленного сустава
|
|
DE10209299A1
(de)
*
|
2002-03-02 |
2003-09-18 |
Aventis Pharma Gmbh |
Cyclische N-substituierte alpha-Iminocarbonsäuren zur selektiven Inhibierung von Kollagenase
|
|
US6716853B2
(en)
|
2002-03-02 |
2004-04-06 |
Aventis Pharma Deutschland Gmbh |
Cyclic N-substituted alpha-imino carboxylic acids for selective inhibition of collogenase
|
|
US7199155B2
(en)
|
2002-12-23 |
2007-04-03 |
Wyeth Holdings Corporation |
Acetylenic aryl sulfonate hydroxamic acid TACE and matrix metalloproteinase inhibitors
|
|
WO2004060892A1
(ja)
*
|
2002-12-27 |
2004-07-22 |
Japan Tobacco Inc. |
縮合ｎ含有ヘテロ環化合物及びその医薬用途
|
|
DE10300015A1
(de)
*
|
2003-01-03 |
2004-07-15 |
Aventis Pharma Deutschland Gmbh |
Iminosäurederivate als Inhibitoren von Matrix-Metallproteinasen
|
|
DE10344936A1
(de)
*
|
2003-09-27 |
2005-04-21 |
Aventis Pharma Gmbh |
Bicyclische Iminosäurederivate als Inhibitoren von Matrix-Metalloproteinasen
|
|
US7205315B2
(en)
|
2003-09-27 |
2007-04-17 |
Sanofi-Aventis Deutschland Gmbh |
Bicyclic imino acid derivatives as inhibitors of matrix metalloproteinases
|
|
DE10351904A1
(de)
*
|
2003-11-06 |
2005-06-09 |
Aventis Pharma Deutschland Gmbh |
Verfahren zur Herstellung von cyclischen N-substituierten alpha-Iminocarbonsäure
|
|
US7244845B2
(en)
*
|
2003-11-06 |
2007-07-17 |
Sanofi-Aventis Deutschland Gmbh |
Process for preparing cyclic N-substituted alpha-imino carboxylic acids
|
|
DE102004004974A1
(de)
*
|
2004-01-31 |
2005-08-18 |
Aventis Pharma Deutschland Gmbh |
Thieno-Iminosäure-Derivate als Inhibitoren von Matrix-Metalloproteinasen
|
|
US7705017B2
(en)
*
|
2004-05-03 |
2010-04-27 |
En Vivo Pharmaceuticals, Inc. |
Compounds for treatment of neurodegenerative diseases
|
|
DE102004031850A1
(de)
*
|
2004-06-30 |
2006-01-26 |
Sanofi-Aventis Deutschland Gmbh |
Substituirte Tetrahydroisochinoline als MMP-Inhibitoren, Verfahren zu ihrer Herstellung und ihre Verwendung als Medikament
|
|
DE102004031620A1
(de)
*
|
2004-06-30 |
2006-02-02 |
Sanofi-Aventis Deutschland Gmbh |
4-Trifluormethoxyphenoxybenzol-4`-sulfonsäuren, Verfahren zu ihrer Herstellung und Verwendung in Arzneimitteln
|
|
US7601838B2
(en)
*
|
2004-12-28 |
2009-10-13 |
Council Of Scientific And Industrial Research |
2-Alkyl/aryl sulphonyl-1,2,3,4-tetrahydro-9H-pyrido (3,4-b) indole-3-carboxylic acid esters/amides useful as antithrombotic agents
|
|
DE102005002500A1
(de)
*
|
2005-01-19 |
2006-07-27 |
Sanofi-Aventis Deutschland Gmbh |
Tetrahydrofuranderivate als Inhibitoren von Matrix-Metalloproteinasen
|
|
DE102005015040A1
(de)
|
2005-03-31 |
2006-10-05 |
Sanofi-Aventis Deutschland Gmbh |
Substituierte Tetrahydroisochinoline als MMP-Inhibitoren, Verfahren zu ihrer Herstellung und ihre Verwendung als Medikament
|
|
CN101189003B
(zh)
|
2005-05-13 |
2012-02-08 |
托波塔吉特英国有限公司 |
Hdac抑制剂的药物制剂
|
|
WO2007045661A1
(en)
*
|
2005-10-20 |
2007-04-26 |
Nordic Bioscience Diagnostics A/S |
Detection or quantification of aggrecan and its fragments
|
|
GB0526257D0
(en)
*
|
2005-12-22 |
2006-02-01 |
Novartis Ag |
Organic compounds
|
|
WO2007141029A1
(en)
*
|
2006-06-08 |
2007-12-13 |
Helmholtz Zentrum München Deutsches Forschungszentrum Für Gesundheit Und Umwelt (Gmbh) |
Specific protease inhibitors and their use in cancer therapy
|
|
WO2009037583A2
(en)
*
|
2007-08-03 |
2009-03-26 |
Nucitec S.A. De C.V. |
Compositions and methods for treatment and prevention of osteoarthritis
|
|
ES2574154T3
(es)
*
|
2007-08-07 |
2016-06-15 |
Abbvie Deutschland Gmbh & Co Kg |
Compuestos de quinolina adecuados para tratar trastornos que responden a la modulación del receptor de serotonina 5-HT6
|
|
EP2231596A4
(en)
|
2007-12-14 |
2012-06-06 |
Univ Georgetown |
INHIBITORS OF HISTONATE ACETYLASE
|
|
CA2722075C
(en)
*
|
2008-04-24 |
2015-11-24 |
Banyu Pharmaceutical Co., Ltd. |
Long-chain fatty acyl elongase inhibitor comprising arylsulfonyl derivative as active ingredient
|
|
WO2010007027A1
(en)
*
|
2008-07-14 |
2010-01-21 |
Novartis Ag |
Selective hydroxamic acid based mmp-12 and mmp-13 inhibitors
|
|
FR2947268B1
(fr)
|
2009-06-30 |
2011-08-26 |
Galderma Res & Dev |
Nouveaux composes benzene-sulfonamides, leur procede de synthese et leur utilisation en medecine ainsi qu'en cosmetique
|
|
FR2947270B1
(fr)
|
2009-06-30 |
2011-08-26 |
Galderma Res & Dev |
Nouveaux composes benzene-sulfonamides, leur procede de synthese et leur utilisation en medecine ainsi qu'en cosmetique
|
|
US20140275108A1
(en)
|
2013-03-15 |
2014-09-18 |
Galderma Research & Development |
Novel benzenesulfonamide compounds, method for synthesizing same, and use thereof in medicine as well as in cosmetics
|
|
WO2017117130A1
(en)
|
2015-12-28 |
2017-07-06 |
The United States Of America, As Represented By The Secretary, Department Of Health & Human Services |
Methods for inhibiting human immunodeficiency virus (hiv) release from infected cells
|
|
ES2695533T3
(es)
|
2016-02-01 |
2019-01-08 |
Galderma Res & Dev |
Compuestos de bencenosulfonamida, método para su síntesis y uso de los mismos en medicina y cosméticos
|
|
CA3082972C
(en)
|
2017-11-27 |
2022-10-11 |
Council Of Scientific & Industrial Research |
Indole (sulfomyl) n-hydroxy benzamide derivatives as selective hdac inhibitors
|
|
WO2025224168A1
(en)
|
2024-04-24 |
2025-10-30 |
Idorsia Pharmaceuticals Ltd |
Aryl sulfone and sulfanone derivatives as orexin receptor modulators
|
|
CN119565781B
(zh)
*
|
2024-12-20 |
2026-01-02 |
中南大学 |
一种金属离子-含氮芳杂环配合物捕收剂及其制备方法和在钨矿浮选中的应用
|